| UniProt ID | M4K1_HUMAN | |
|---|---|---|
| UniProt AC | Q92918 | |
| Protein Name | Mitogen-activated protein kinase kinase kinase kinase 1 | |
| Gene Name | MAP4K1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 833 | |
| Subcellular Localization | ||
| Protein Description | Serine/threonine-protein kinase, which may play a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway. May play a role in hematopoietic lineage decisions and growth regulation. Able to autophosphorylate.. | |
| Protein Sequence | MDVVDPDIFNRDPRDHYDLLQRLGGGTYGEVFKARDKVSGDLVALKMVKMEPDDDVSTLQKEILILKTCRHANIVAYHGSYLWLQKLWICMEFCGAGSLQDIYQVTGSLSELQISYVCREVLQGLAYLHSQKKIHRDIKGANILINDAGEVRLADFGISAQIGATLARRLSFIGTPYWMAPEVAAVALKGGYNELCDIWSLGITAIELAELQPPLFDVHPLRVLFLMTKSGYQPPRLKEKGKWSAAFHNFIKVTLTKSPKKRPSATKMLSHQLVSQPGLNRGLILDLLDKLKNPGKGPSIGDIEDEEPELPPAIPRRIRSTHRSSSLGIPDADCCRRHMEFRKLRGMETRPPANTARLQPPRDLRSSSPRKQLSESSDDDYDDVDIPTPAEDTPPPLPPKPKFRSPSDEGPGSMGDDGQLSPGVLVRCASGPPPNSPRPGPPPSTSSPHLTAHSEPSLWNPPSRELDKPPLLPPKKEKMKRKGCALLVKLFNGCPLRIHSTAAWTHPSTKDQHLLLGAEEGIFILNRNDQEATLEMLFPSRTTWVYSINNVLMSLSGKTPHLYSHSILGLLERKETRAGNPIAHISPHRLLARKNMVSTKIQDTKGCRACCVAEGASSGGPFLCGALETSVVLLQWYQPMNKFLLVRQVLFPLPTPLSVFALLTGPGSELPAVCIGVSPGRPGKSVLFHTVRFGALSCWLGEMSTEHRGPVQVTQVEEDMVMVLMDGSVKLVTPEGSPVRGLRTPEIPMTEAVEAVAMVGGQLQAFWKHGVQVWALGSDQLLQELRDPTLTFRLLGSPRLECSGTISPHCNLLLPGSSNSPASASRVAGITGL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 17 | Phosphorylation | NRDPRDHYDLLQRLG CCCCCHHHHHHHHHC | 16.75 | 28796482 | |
| 27 | Phosphorylation | LQRLGGGTYGEVFKA HHHHCCCCHHHHHHH | 31.46 | 29978859 | |
| 28 | Phosphorylation | QRLGGGTYGEVFKAR HHHCCCCHHHHHHHH | 17.98 | 29978859 | |
| 33 | Ubiquitination | GTYGEVFKARDKVSG CCHHHHHHHHHCCCC | 47.92 | 29967540 | |
| 37 | Ubiquitination | EVFKARDKVSGDLVA HHHHHHHCCCCCEEE | 32.52 | 29967540 | |
| 46 | Ubiquitination | SGDLVALKMVKMEPD CCCEEEEEEEECCCC | 31.73 | 29967540 | |
| 49 | Ubiquitination | LVALKMVKMEPDDDV EEEEEEEECCCCCCH | 33.76 | 29967540 | |
| 165 | Phosphorylation | ISAQIGATLARRLSF CCHHHHHHHHHHHHC | 18.75 | 24362026 | |
| 171 | Phosphorylation | ATLARRLSFIGTPYW HHHHHHHHCCCCCCC | 17.01 | 28450419 | |
| 175 | Phosphorylation | RRLSFIGTPYWMAPE HHHHCCCCCCCCCHH | 14.37 | 28450419 | |
| 177 | Phosphorylation | LSFIGTPYWMAPEVA HHCCCCCCCCCHHHH | 13.98 | 28450419 | |
| 230 | Phosphorylation | VLFLMTKSGYQPPRL HEEEEECCCCCCCCH | 33.30 | 26657352 | |
| 232 | Phosphorylation | FLMTKSGYQPPRLKE EEEECCCCCCCCHHH | 25.57 | 11278340 | |
| 258 | Phosphorylation | IKVTLTKSPKKRPSA EEEEECCCCCCCCCH | 36.39 | - | |
| 296 | Ubiquitination | DKLKNPGKGPSIGDI HHHCCCCCCCCCCCC | 69.75 | 29967540 | |
| 320 | Phosphorylation | AIPRRIRSTHRSSSL CCCCCHHCCCCCCCC | 26.62 | - | |
| 324 | Phosphorylation | RIRSTHRSSSLGIPD CHHCCCCCCCCCCCC | 19.37 | 23401153 | |
| 325 | Phosphorylation | IRSTHRSSSLGIPDA HHCCCCCCCCCCCCH | 29.55 | 28450419 | |
| 326 | Phosphorylation | RSTHRSSSLGIPDAD HCCCCCCCCCCCCHH | 31.68 | 23401153 | |
| 349 | Phosphorylation | RKLRGMETRPPANTA HHHCCCCCCCCCCCC | 39.31 | - | |
| 355 | Phosphorylation | ETRPPANTARLQPPR CCCCCCCCCCCCCCC | 18.43 | 24362026 | |
| 366 | Phosphorylation | QPPRDLRSSSPRKQL CCCCHHCCCCCCHHH | 42.33 | 15302935 | |
| 368 | Phosphorylation | PRDLRSSSPRKQLSE CCHHCCCCCCHHHCC | 29.94 | 15302935 | |
| 374 | Phosphorylation | SSPRKQLSESSDDDY CCCCHHHCCCCCCCC | 32.70 | 17192257 | |
| 376 | Phosphorylation | PRKQLSESSDDDYDD CCHHHCCCCCCCCCC | 35.37 | 17192257 | |
| 377 | Phosphorylation | RKQLSESSDDDYDDV CHHHCCCCCCCCCCC | 40.79 | 17192257 | |
| 381 | Phosphorylation | SESSDDDYDDVDIPT CCCCCCCCCCCCCCC | 22.49 | 17192257 | |
| 388 | Phosphorylation | YDDVDIPTPAEDTPP CCCCCCCCCCCCCCC | 35.15 | 22210691 | |
| 393 | Phosphorylation | IPTPAEDTPPPLPPK CCCCCCCCCCCCCCC | 29.24 | 28111955 | |
| 405 | Phosphorylation | PPKPKFRSPSDEGPG CCCCCCCCCCCCCCC | 31.71 | 22115753 | |
| 407 | Phosphorylation | KPKFRSPSDEGPGSM CCCCCCCCCCCCCCC | 49.92 | 22115753 | |
| 413 | Phosphorylation | PSDEGPGSMGDDGQL CCCCCCCCCCCCCCC | 23.79 | 21082442 | |
| 421 | Phosphorylation | MGDDGQLSPGVLVRC CCCCCCCCCCEEEEE | 16.24 | 23401153 | |
| 430 | Phosphorylation | GVLVRCASGPPPNSP CEEEEECCCCCCCCC | 56.30 | 28450419 | |
| 436 | Phosphorylation | ASGPPPNSPRPGPPP CCCCCCCCCCCCCCC | 28.23 | 28450419 | |
| 444 | Phosphorylation | PRPGPPPSTSSPHLT CCCCCCCCCCCCCCC | 46.85 | 28450419 | |
| 445 | Phosphorylation | RPGPPPSTSSPHLTA CCCCCCCCCCCCCCC | 38.71 | 23684312 | |
| 446 | Phosphorylation | PGPPPSTSSPHLTAH CCCCCCCCCCCCCCC | 46.33 | 28450419 | |
| 447 | Phosphorylation | GPPPSTSSPHLTAHS CCCCCCCCCCCCCCC | 19.21 | 28450419 | |
| 451 | Phosphorylation | STSSPHLTAHSEPSL CCCCCCCCCCCCCHH | 21.20 | 28450419 | |
| 454 | Phosphorylation | SPHLTAHSEPSLWNP CCCCCCCCCCHHCCC | 49.06 | 28450419 | |
| 457 | Phosphorylation | LTAHSEPSLWNPPSR CCCCCCCHHCCCCCC | 41.80 | 28450419 | |
| 463 | Phosphorylation | PSLWNPPSRELDKPP CHHCCCCCCCCCCCC | 39.38 | 28450419 | |
| 563 | Phosphorylation | SGKTPHLYSHSILGL CCCCCHHHHHHHHHH | 10.99 | 28064214 | |
| 586 | Phosphorylation | GNPIAHISPHRLLAR CCCCCCCCHHHHHHH | 12.56 | 24362026 | |
| 594 | Ubiquitination | PHRLLARKNMVSTKI HHHHHHHHCCCCCCC | 43.73 | 29967540 | |
| 598 | Phosphorylation | LARKNMVSTKIQDTK HHHHCCCCCCCCCCC | 17.14 | - | |
| 599 | Phosphorylation | ARKNMVSTKIQDTKG HHHCCCCCCCCCCCC | 22.28 | - | |
| 600 | Ubiquitination | RKNMVSTKIQDTKGC HHCCCCCCCCCCCCC | 30.75 | 29967540 | |
| 697 | Phosphorylation | TVRFGALSCWLGEMS EEEHHHHHHHHHCCC | 11.60 | 30257219 | |
| 733 | Phosphorylation | DGSVKLVTPEGSPVR CCEEEEECCCCCCCC | 26.51 | 30108239 | |
| 737 | Phosphorylation | KLVTPEGSPVRGLRT EEECCCCCCCCCCCC | 20.68 | 30576142 | |
| 797 | Phosphorylation | LTFRLLGSPRLECSG EEEEECCCCCCEECC | 13.55 | 20562096 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 165 | T | Phosphorylation | Kinase | MAP4K1 | Q92918 | GPS |
| 171 | S | Phosphorylation | Kinase | PRKD1 | Q15139 | PSP |
| 381 | Y | Phosphorylation | Kinase | SYK | P43405 | GPS |
| 381 | Y | Phosphorylation | Kinase | SYK | Q15046 | PhosphoELM |
| - | K | Ubiquitination | E3 ubiquitin ligase | FBXW8 | Q8N3Y1 | PMID:24658274 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of M4K1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of M4K1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| GRB2_HUMAN | GRB2 | physical | 9346925 | |
| NCK1_HUMAN | NCK1 | physical | 9346925 | |
| EGFR_HUMAN | EGFR | physical | 9346925 | |
| M3K7_HUMAN | MAP3K7 | physical | 10224067 | |
| M3K11_HUMAN | MAP3K11 | physical | 11053428 | |
| CRK_HUMAN | CRK | physical | 9891069 | |
| CRKL_HUMAN | CRKL | physical | 9891069 | |
| GRB2_HUMAN | GRB2 | physical | 11279207 | |
| PP4C_HUMAN | PPP4C | physical | 15364934 | |
| SPY1_HUMAN | SPRY1 | physical | 19915061 | |
| NCK1_HUMAN | NCK1 | physical | 22974441 | |
| TM101_HUMAN | TMEM101 | physical | 21988832 | |
| SKP1_HUMAN | SKP1 | physical | 24362026 | |
| RBX1_HUMAN | RBX1 | physical | 24362026 | |
| CUL7_HUMAN | CUL7 | physical | 24362026 | |
| FBXW8_HUMAN | FBXW8 | physical | 24362026 | |
| FBXW7_HUMAN | FBXW7 | physical | 24362026 | |
| M4K1_HUMAN | MAP4K1 | physical | 24362026 | |
| PP4C_HUMAN | PPP4C | physical | 24362026 | |
| CAR11_HUMAN | CARD11 | physical | 19706536 | |
| M4K1_HUMAN | MAP4K1 | physical | 19706536 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405; SER-407; SER-413AND SER-421, AND MASS SPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-374; SER-376;SER-377; SER-421 AND SER-586, AND MASS SPECTROMETRY. | |
| "Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry."; Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.; Mol. Cell. Proteomics 6:537-547(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-374; SER-376; TYR-381;SER-407; SER-413; SER-421 AND SER-586, AND MASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-366 AND SER-368, ANDMASS SPECTROMETRY. | |